Recurrent stroke after lobar and deep intracerebral hemorrhage: A hospital-based cohort study

Cerebrovascular Diseases

Volumn 32, Issue 3, 2011, Pages 283-288

  Weimar, C ^a   Benemann, J ^a   Terborg, C ^b   Walter, U ^c   Weber, R ^a   Diener, H C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Anticoagulation; Antiplatelets; Hemorrhagic stroke; Intracerebral hemorrhage; Prognosis; Recurrent stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DEEP INTRACEREBRAL HEMORRHAGE; DIABETES MELLITUS; DRUG MEGADOSE; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; LOBAR INTRACEREBRAL HEMORRAHGE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; STROKE; STROKE PATIENT; TELECONSULTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HOSPITALS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 80052328702     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000330643     Document Type: Article

References (21)

1. Hanger HC, Wilkinson TJ, Fayez-Iskander N, Sainsbury R: The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2007; 78: 836-840. (Pubitemid 47204588)
2. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM: Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003; 34: 1710-1716. (Pubitemid 36842632)
3. Hacke W: The dilemma of reinstituting anticoagulation for patients with cardioembolic sources and intracranial hemorrhage: How wide is the strait between Skylla and Karybdis? Arch Neurol 2000; 57: 1682-1684.
4. Majeed A, Kim YK, Roberts RS, Holmström M, Schulman S: Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010; 41: 2860-2866.
5. PROGRESS Collaborative Group: Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
6. Perry HM Jr, Davis BR, Price TR, et al: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: The Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465-471. (Pubitemid 30484480)
7. Bailey RD, Hart RG, Benavente O, Pearce LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001; 56: 773-777. (Pubitemid 32240098)
8. Sacco S, Marini C, Toni D, Olivieri L, Carolei A: Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009; 40: 394-399.
9. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS: Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010; 41: 2606-2611.
10. Hill MD, Silver FL, Austin PC, Tu JV: Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000; 31: 123-127. (Pubitemid 30035763)
11. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ: Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002; 59: 205-209. (Pubitemid 34779178)
12. Fogelholm R, Murros K, Rissanen A, Avikainen S: Long term survival after primary intracerebral haemorrhage: A retrospective population based study. J Neurol Neurosurg Psychiatry 2005; 76: 1534-1538. (Pubitemid 41531701)
13. Hankey GJ, Jamrozik K, Broadhurst RJ, et al: Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998; 29: 2491-2500. (Pubitemid 28543996)
14. Viswanathan A, Rakich SM, Engel C, et al: Antiplatelet use after intracerebral hemorrhage. Neurology 2006; 66: 206-209. (Pubitemid 43970155)
15. Biffi A, Halpin A, Towfighi A, et al: Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75: 693-698.
16. O'Donnell HC, Rosand J, Knudsen KA, et al: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-245. (Pubitemid 30058955)
17. Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA: Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol 2008; 65: 1313-1318.
18. Romualdi E, Micieli E, Ageno W, Squizzato A: Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost 2009; 101: 290-297.
19. Hawryluk GW, Austin JW, Furlan JC, Lee JB, O'Kelly C, Fehlings MG: Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 2010; 8: 1500-1508.
20. Hart R, Benavente O, McBride R, Pearce L: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501. (Pubitemid 29482392)
21. Connolly SJ, Ezekowitz MD, Yusuf S, et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.